| pubmed-article:16108471 | pubmed:abstractText | Medical groups continue to explore ancillary service development to address patient care and generate revenue. However, the regulatory environment surrounding ancillary service arrangements changed as the Department of Health and Human Services Office of Inspector General rejected a "turn-key" pathology laboratory service arrangement in Advisory Opinion 04-17 (AO-04-17). This article considers how this and other recent guidance affects what medical groups can and cannot do regarding ancillary services. | lld:pubmed |
